Tag: aim:vrp
April 9, 2019
Verona Pharma Granted Key EU Patent for Late-stage COPD Clinical Candidate Ensifentrine
Verona Pharma (NASDAQ:VRNA, AIM:VRP) has announced that the European Patent Office granted another key patent regarding its lead development candidate,... September 6, 2018